These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 33650737)
41. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC Lancet Infect Dis; 2022 Sep; 22(9):1293-1302. PubMed ID: 35753318 [TBL] [Abstract][Full Text] [Related]
42. Recalling the universal health coverage vision and equity in the COVID-19 vaccine distribution plan. Adejumo OA; Adejumo OA Pan Afr Med J; 2021; 39():197. PubMed ID: 34603578 [TBL] [Abstract][Full Text] [Related]
43. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions. Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I Front Public Health; 2021; 9():709127. PubMed ID: 34422750 [TBL] [Abstract][Full Text] [Related]
44. Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective. McAdams D; McDade KK; Ogbuoji O; Johnson M; Dixit S; Yamey G BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33257418 [No Abstract] [Full Text] [Related]
45. COVID-19 Vaccines: Ensuring Social Justice and Health Equity among Refugees in Africa. Manirambona E; Hague O; Trajano LF; Killen A; Wilkins L; Nkeshimana M; Lucero-Prisno Iii DE Ann Glob Health; 2021; 87(1):106. PubMed ID: 34786354 [TBL] [Abstract][Full Text] [Related]
46. Inequities in the deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region, 2020-2021. Hasan Q; Elfakki E; Fahmy K; Mere O; Ghoniem A; Langar H; Musa N; Attia R; Othman MM; Samhouri D; Chaudhri I; Abubakar A; Hajjeh R; Hutin YJ BMJ Glob Health; 2022 Jun; 7(Suppl 4):. PubMed ID: 35764354 [TBL] [Abstract][Full Text] [Related]
47. Ensuring the global COVID-19 vaccine equity: Universal vaccine access strategy in the context of low and-middle-income countries. Parray AA; Yadav UN; Das A; Ali AM; Mollick S; Saha S; Mistry SK Glob Public Health; 2022 Apr; 17(4):614-621. PubMed ID: 35050840 [No Abstract] [Full Text] [Related]
48. A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review. Pushkaran A; Chattu VK; Narayanan P BMJ Glob Health; 2023 Oct; 8(10):. PubMed ID: 37793808 [TBL] [Abstract][Full Text] [Related]
49. Vaccine nationalism is not unethical from a political ethics perspective: Learning from the global COVID-19 vaccine distribution failure. Shao Q Health Policy; 2024 Mar; 141():104996. PubMed ID: 38266331 [TBL] [Abstract][Full Text] [Related]
50. COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries. Mazur A; Benitez S; Chuffart-Finsterwald S; La Rotta R; Hampton LM Vaccine; 2021 Dec; 39(49):7128-7130. PubMed ID: 34732277 [No Abstract] [Full Text] [Related]
51. Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants. Liu F; Zhao Z; Ma C; Nie X; Wu A; Li X Epidemiol Infect; 2022 Jan; 150():e46. PubMed ID: 35067231 [TBL] [Abstract][Full Text] [Related]
53. Pandemic preparedness and response: beyond the Access to COVID-19 Tools Accelerator. Saxena A; Baker BK; Banda A; Herlitz A; Miller J; Karrar K; Fleurbaey M; Chiwa E; Atuire CA; Hirose I; Hassoun N BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650015 [TBL] [Abstract][Full Text] [Related]
54. Multivalue ethical framework for fair global allocation of a COVID-19 vaccine. Liu Y; Salwi S; Drolet BC J Med Ethics; 2020 Aug; 46(8):499-501. PubMed ID: 32532826 [TBL] [Abstract][Full Text] [Related]
55. Clinical development and approval of COVID-19 vaccines. Kalinke U; Barouch DH; Rizzi R; Lagkadinou E; Türeci Ö; Pather S; Neels P Expert Rev Vaccines; 2022 May; 21(5):609-619. PubMed ID: 35157542 [TBL] [Abstract][Full Text] [Related]
57. Voluntariness or legal obligation? An ethical analysis of two instruments for fairer global access to COVID-19 vaccines. Voit K; Timmermann C; Orzechowski M; Steger F Front Public Health; 2023; 11():995683. PubMed ID: 36778578 [TBL] [Abstract][Full Text] [Related]
59. Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity. Louden EM Yale J Biol Med; 2022 Sep; 95(3):379-387. PubMed ID: 36187418 [TBL] [Abstract][Full Text] [Related]
60. Shared health governance, mutual collective accountability, and transparency in COVAX: A qualitative study triangulating data from document sampling and key informant interviews. Gorodensky A; Grundy Q; Persaud N; Kohler JC J Glob Health; 2023 Dec; 13():04165. PubMed ID: 38063440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]